查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594997

全球蛋白质定序市场

Protein Sequencing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球蛋白质定序市场将达到 15 亿美元

全球蛋白质定序市场预计 2023 年为 13 亿美元，预计到 2030 年将达到 15 亿美元，2023-2030 年分析期间复合年增长率为 2.9%。质谱技术是本报告分析的细分市场之一，预计复合年增长率为 2.7%，到分析期结束时将达到 9.735 亿美元。在分析期间，Edman 分解技术部门的复合年增长率预计为 3.2%。

美国市场预估为3.386亿美元，中国预期复合年增长率为2.7%

预计 2023 年美国蛋白质定序市场规模将达到 3.386 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达2.449亿美元，2023-2030年分析期间复合年增长率为2.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.4% 和 2.4%。在欧洲，德国的复合年增长率预计为 3.1%。

全球蛋白质定序市场 - 主要趋势与驱动因素总结

什么是蛋白质定序以及为什么需要它？

蛋白质定序是一种用于确定蛋白质氨基酸序列的分析过程，揭示有关其结构和功能的重要资讯。蛋白质定序中使用的主要技术包括埃德曼降解和质谱分析，使研究人员能够识别、表征和研究复杂生物样品中的蛋白质组成。了解蛋白质序列可以深入了解细胞过程、疾病机制和基因表现，使该技术成为生物技术和药物研究的基石。除了基础科学之外，蛋白质定序在标靶治疗、疫苗和诊断工具的开发中也发挥着至关重要的作用。确定蛋白质的精确结构和序列使研究人员和临床医生能够识别与特定疾病相关的生物标记物，从而实现更个人化的医学方法。蛋白质定序的应用范围正在从蛋白质功能的基础研究扩展到蛋白质体学、免疫学和合成生物学的应用。蛋白质定序的每一次突破都揭示了生物系统中新的​​复杂性，并提供了对蛋白质如何控制生命基本过程的更深入的了解。

技术创新如何形塑蛋白质序列？

最近的技术创新显着提高了蛋白质定序的速度、准确性和成本，将其转变为高通量过程。传统的 Edman 降解虽然准确，但非常耗时且范围有限，而当今基于质谱的方法可以快速处理大型蛋白质资料集。串联式质谱质谱 (MS/MS) 等技术创新使研究人员能够将胜肽分解成更小的片段并对序列测定，从而获得更详细、更全面的资料。此外，机器学习和生物资讯学的进步使得能够更有效地分析大规模蛋白质资料，并提高高保真度绘製蛋白质图谱的能力。奈米孔定序和基于次世代定序(NGS) 的蛋白质体学等新兴技术有望实现更高的精度和覆盖范围，突破了蛋白质定序所能实现的界限。定序设备的不断小型化和基于人工智慧的分析的整合使得蛋白质测序更容易实现并适用于各种科学领域。这些进步对药物研究和个人化医疗产生了特殊的影响，其中快速且准确的蛋白质识别加速了药物发现和精确诊断。

是什么推动了对蛋白质定序解决方案的需求？

对蛋白质定序技术的需求受到跨产业的广泛应用的推动，包括生物技术、製药和环境研究。製药公司正在使用蛋白质定序来发现新的治疗标靶并表征单株抗体等生技药品，这对于治疗癌症和自体免疫疾病非常重要。在农业生物技术中，蛋白质定序正在帮助开发抗虫作物和更有效的食品加工酶解决方案。在免疫学领域，蛋白质定序也能够研究免疫系统蛋白质，这是疫苗开发和自体免疫疾病研究的基础。环境科学家使用蛋白质序列来研究微生物生态系统并深入了解生物多样性和生物修復过程。临床诊断产业也是蛋白质定序的主要消费者。蛋白质定序用于识别疾病特异性生物标记物，以实现更准确的诊断。总体而言，蛋白质定序的应用正在迅速扩大。因为该技术提供了需要准确且可操作的蛋白质资讯的多学科解决方案。

推动蛋白质定序市场成长的因素有哪些？

由于技术、商业性和社会因素的结合，蛋白质定序市场正在迅速扩大。新一代定序 (NGS) 技术的进步，加上运算能力的增强，使定序速度比以往更快、更具成本效益。製药和生物技术产业对药物发现和开发的高通量测序的需求是一个主要驱动力，特别是当生技药品和生物仿製药作为治疗剂变得越来越流行时。消费者对精准医疗的需求也促进了市场的成长。蛋白质定序在识别患者特异性蛋白质谱方面发挥重要作用，从而为标靶治疗方案提供资讯。此外，与蛋白质组学和基因组学相关的学术和临床研究的激增刺激了对能够提供全面蛋白质分析的创新测序方法的需求。此外，慢性病的增加和对个人化治疗的需求不断增长正在推动对蛋白质组学的投资，其中蛋白质测序发挥重要作用。最后，生物技术和个人化医疗领域的政府支持政策和资金正在加速研究机构和私人公司的采用。这些因素共同凸显了蛋白质定序在提昇科学和临床能力、确保未来持续成长和相关性方面所发挥的重要作用。

部分

技术（质谱、埃德曼降解）；应用（生物治疗、基因工程、其他应用）；最终用途（学术机构/研究中心、製药/生物技术公司、其他最终用途）

受访企业举例（共34家）

  • Agilent Technologies
  • Bioinformatics Solution
  • Charles River Laboratories
  • Proteome Factory
  • Rapid Novor
  • Selvita
  • SGS（SA）
  • Shimadzu Corp.
  • Thermo Fischer Inc.
  • Water Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP22661

Global Protein Sequencing Market to Reach US$1.5 Billion by 2030

The global market for Protein Sequencing estimated at US$1.3 Billion in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Mass Spectrometry Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis period. Growth in the Edman Degradation Technology segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$338.6 Million While China is Forecast to Grow at 2.7% CAGR

The Protein Sequencing market in the U.S. is estimated at US$338.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$244.9 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Protein Sequencing Market - Key Trends & Drivers Summarized

What Is Protein Sequencing and Why Is It Essential?

Protein sequencing is the analytical process used to determine the amino acid sequence of proteins, unlocking crucial information about their structure and function. The primary techniques utilized in protein sequencing include Edman degradation and mass spectrometry, which allow researchers to identify, characterize, and study protein compositions in complex biological samples. Understanding protein sequences provides insights into cellular processes, disease mechanisms, and genetic expression, making this technology a cornerstone in biotechnology and pharmaceutical research. Beyond basic science, protein sequencing also plays a pivotal role in developing targeted therapies, vaccines, and diagnostic tools. By identifying the exact structure and sequence of proteins, researchers and clinicians can pinpoint biomarkers associated with specific diseases, enabling more personalized approaches in medicine. The scope of protein sequencing has expanded from foundational studies of protein function to applications in proteomics, immunology, and synthetic biology. With each breakthrough, protein sequencing reveals new complexities of biological systems, offering a deeper understanding of how proteins govern the essential processes of life.

How Are Technological Innovations Shaping Protein Sequencing?

Recent technological advancements have significantly enhanced the speed, accuracy, and affordability of protein sequencing, transforming it into a high-throughput process. Traditional Edman degradation, while precise, was slow and limited in scope, but today’s mass spectrometry-based methods can process large protein datasets rapidly. Innovations such as tandem mass spectrometry (MS/MS) allow researchers to sequence peptides by breaking them down into smaller fragments, providing more detailed and comprehensive data. Furthermore, advancements in machine learning and bioinformatics have enabled more effective analysis of large-scale protein data, enhancing the ability to map proteins with high fidelity. Emerging techniques, including nanopore sequencing and next-generation sequencing (NGS)-based proteomics, promise further accuracy and scope, pushing the boundaries of what protein sequencing can achieve. With the ongoing miniaturization of sequencing instruments and the integration of AI-based analysis, protein sequencing is becoming more accessible and applicable to diverse scientific fields. These advancements are particularly impactful in pharmaceutical research and personalized medicine, where rapid, accurate protein identification can accelerate drug discovery and precision diagnostics.

Who Is Driving the Demand for Protein Sequencing Solutions?

The demand for protein sequencing technologies is being driven by a wide range of applications across industries, including biotechnology, pharmaceuticals, and environmental research. Pharmaceutical companies are leveraging protein sequencing to discover novel therapeutic targets and to characterize biologics like monoclonal antibodies, which are crucial in cancer and autoimmune disease treatment. In agricultural biotechnology, protein sequencing helps develop pest-resistant crops and more efficient enzyme solutions for food processing. The field of immunology also benefits from protein sequencing, as it enables the study of immune system proteins, which is fundamental in vaccine development and autoimmune disease research. Environmental scientists utilize protein sequencing to study microbial ecosystems, gaining insights into biodiversity and bioremediation processes. The clinical diagnostics industry also represents a major consumer of protein sequencing, where it is used to identify disease-specific biomarkers for more accurate diagnoses. Overall, the applications of protein sequencing are expanding rapidly, as this technology provides solutions that span multiple fields, each requiring precise and actionable protein information.

What Factors Are Driving Growth in the Protein Sequencing Market?

The protein sequencing market is expanding rapidly due to a combination of technological, commercial, and societal factors. Advances in next-generation sequencing (NGS) technology, coupled with increasing computational capabilities, are enabling more rapid and cost-effective sequencing than ever before. The demand from pharmaceutical and biotechnology industries for high-throughput sequencing for drug discovery and development is a major driver, particularly as biologics and biosimilars gain popularity as therapeutic agents. Consumer demand for precision medicine is also contributing to market growth, as protein sequencing is fundamental in identifying patient-specific protein profiles that inform targeted treatment options. Additionally, the surge in academic and clinical research related to proteomics and genomics is stimulating the need for innovative sequencing methods that can provide comprehensive protein analysis. Furthermore, the increasing prevalence of chronic diseases and the growing need for personalized treatments are driving investment in proteomics, where protein sequencing plays an indispensable role. Lastly, supportive government policies and funding in the fields of biotechnology and personalized healthcare are accelerating adoption across research institutions and private sector organizations. Together, these factors underscore the critical role of protein sequencing in advancing scientific and clinical capabilities, ensuring its continued growth and relevance in the years ahead.

SCOPE OF STUDY:

The report analyzes the Protein Sequencing market in terms of US$ Thousand by the following Application; End-Use; Technology, and Geographic Regions/Countries:

Segments:

Technology (Mass Spectrometry, Edman Degradation); Application (Biotherapeutics, Genetic Engineering, Other Applications); End-Use (Academic Institutes & Research Centers, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Agilent Technologies
  • Bioinformatics Solution
  • Charles River Laboratories
  • Proteome Factory
  • Rapid Novor
  • Selvita
  • SGS (SA)
  • Shimadzu Corp.
  • Thermo Fischer Inc.
  • Water Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Protein Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Precision Medicine and Personalized Therapies Drives Growth in Protein Sequencing Technologies
    • Rising Use of Protein Sequencing in Drug Discovery and Development Expands Addressable Market for Biotechnology and Pharma Applications
    • Advances in Mass Spectrometry and High-Throughput Sequencing Propel Innovations and Efficiency in Protein Sequencing Processes
    • Growing Need for Proteomic Data to Understand Complex Diseases Spurs Adoption of Protein Sequencing in Biomedical Research
    • Integration of Artificial Intelligence and Machine Learning in Protein Sequencing Enhances Data Analysis, Accuracy, and Predictive Insights
    • Expanding Applications of Protein Sequencing in Biomarker Discovery Accelerates Demand in Cancer, Cardiovascular, and Neurological Disease Studies
    • Increasing Prevalence of Chronic Diseases and Personalized Treatment Approaches Drive Market Growth for Advanced Protein Analysis Techniques
    • Miniaturization and Automation of Protein Sequencing Tools Generate Opportunities for Point-of-Care Diagnostics and Clinical Applications
    • Rising Demand for Proteomic Data in Agricultural Biotechnology Propels Use of Protein Sequencing in Crop and Livestock Improvement Programs
    • Growing Adoption of Next-Generation Sequencing (NGS) and Single-Molecule Sequencing Drives Technological Advancements in Protein Sequencing
    • Increased Awareness of Protein Sequencing in Environmental and Marine Biology Expands Applications Beyond Traditional Life Sciences
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Edman Degradation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Biotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Protein Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION